MONITORING HEALTH INEQUALITY

Similar documents
State of InequalIty. Reproductive, maternal, newborn and child health. executi ve S ummary

Multidrug-/ rifampicinresistant. (MDR/RR-TB): Update 2017

WHO/NMH/TFI/11.3. Warning about the dangers of tobacco. Executive summary. fresh and alive

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

Photo Book: Identify Signs of Illness

WHO Library Cataloguing-in-Publication Data. World health statistics 2011.

BEST PRACTICES IN MICROPLANNING FOR CHILDREN OUT OF THE HOUSEHOLD: AN EXAMPLE FROM NORTHERN NIGERIA

Checklist for assessing the gender responsiveness of sexual and reproductive health policies. Pilot document for adaptation to national contexts

MONITORING THE BUILDING BLOCKS OF HEALTH SYSTEMS: A HANDBOOK OF INDICATORS AND THEIR MEASUREMENT STRATEGIES

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc

WHO Library Cataloguing-in-Publication Data. World health statistics 2015.

TECHNICAL UPDATE HIV DRUG RESISTANCE HIV DRUG RESISTANCE SURVEILLANCE GUIDANCE: 2015 UPDATE

BEST PRACTICES FOR PLANNING A VACCINATION CAMPAIGN FOR AN ENTIRE POPULATION

biological agents volume 100 B A review of human carcinogens iarc monographs on the evaluation of carcinogenic risks to humans

GOOD PHARMACOPOEIAL PRACTICES

GUIDANCE FOR SAMPLING ART CLINICS IN COUNTRIES COMBINING SURVEILLANCE OF PRE-TREATMENT HIV DRUG RESISTANCE AND ACQUIRED HIV DRUG RESISTANCE AT 12 AND

CUTANEOUS LEISHMANIASIS

Latent tuberculosis infection

WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC,

WEB ANNEX I. REPORT ON COST-EFFECTIVENESS OF IMPLEMENTING AN INDETERMINATE RANGE FOR EARLY INFANT DIAGNOSIS OF HIV

Overheads. Complementary Feeding Counselling a training course. World Health Organization

CLINDAMYCIN PALMITATE

DECLARATION ON ACCELERATION OF HIV PREVENTION EFFORTS IN THE AFRICAN REGION

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

Intercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net

NATIONAL AIDS PROGRAMME MANAGEMENT A SET OF TRAINING MODULES

Raising tobacco taxes in Bangladesh in FY : An opportunity for development

2004 Update. Luxembourg

Volume 10 Cervix Cancer Screening

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

2004 Update. Serbia and Montenegro

WHO Emergency Risk Communication

Adult rate (%) 0.1 Low estimate. 0.0 High estimate 0.2

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

Second intercountry meeting on the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network

preventing suicide Regional strategy on

Diabetes. Halt the diabetes epidemic

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

WHO GUIDANCE NOTE. Comprehensive cervical cancer prevention and control: a healthier future for girls and women

EMTRICITABINE AND TENOFOVIR TABLETS

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

NATIONAL COORDINATION MECHANISM FOR TOBACCO CONTROL A Model for the African Region

2004 Update. Georgia

IMPLEMENTATION OF THE REVISED GENERAL

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

Guidelines for scaling-up the 100% condom use programme:

2004 Update. Bahrain

2004 Update. Seychelles

2004 Update. Maldives

HIV/AIDS estimates. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. UNAIDS/WHO Epidemiological Fact Sheet Update.

Adult rate (%) 0.1 Low estimate. 0.0 High estimate 0.2

2004 Update. Hungary

2004 Update. Mauritius

In 1993 and 1996, 1 percent of IV drug users tested were positive. In 2000, 193 injecting drug users were screened and none tested positive.

2004 Update. Eritrea

Cancer Incidence in Five Continents. Volume VIII

2004 Update. Suriname

From raw data to easily understood gender statistics. United Nations Statistics Division

Module 9 Strategic information

Summary report on the WHO-EM/WRH/104/E

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

Latent tuberculosis infection

2004 Update. Lebanon

2004 Update. Syrian Arab Republic

WHO guidelines on the management of health complications from female genital mutilation Policy brief

Public health relevant virological features of Influenza A(H7N9) causing human infection in China

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

Public Health Laboratories for Alert and Response. A WHO Guidance Document

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

HIV/AIDS estimates. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. UNAIDS/WHO Epidemiological Fact Sheet Update.

Inequality in Reproductive, Maternal and Child Health in Indonesia

WHO IMPLEMENTATION TOOL FOR PRE-EXPOSURE PROPHYLAXIS (PrEP) OF HIV INFECTION

Technical consultation on reducing sugar intake in the Eastern Mediterranean Region

2004 Update. Barbados

The short version. WHO recommendations on prevention and management INTRODUCTION. of tobacco use and second-hand smoke exposure in pregnancy

SURVEILLANCE OF ANTIRETROVIRAL DRUG TOXICITY WITHIN ANTIRETROVIRAL TREATMENT PROGRAMMES. Main messages

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Reaching the Unreached is UHC enough? Dr Mickey Chopra, Chief of Health, UNICEF, NYHQ

2004 Update. Armenia

LEADING THE HEALTH SECTOR RESPONSE TO HIV/AIDS

Harnessing the power of vaccines using the public and private sector: A 21 st century model for international development

World Immunization Week 2013

WHO Rotavirus Vaccine Update Dr. Fatima Serhan WHO/FWC/IVB/EPI

MAPS ON GLOBAL TOBACCO CONTROL POLICY DATA

Decade of Vaccines Global Vaccine Action Plan. GVAP Secretariat report 2015 Update actions on taken by the secretariat in response to previous reports

2004 Update. Croatia

HIV/AIDS estimates. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. UNAIDS/WHO Epidemiological Fact Sheet Update.

2004 Update. Belarus

Social Determinants of Health

Equatorial Guinea. Epidemiological Fact Sheet on HIV and AIDS Update. July 2008 / Version 0.1 beta. Core data on epidemiology and response

:i iiii ï {:] liii M1!11111[.1i

Progress with IPV introduction Polio Partners Group PPG 16 June 2014

PRINCIPLES FOR EVALUATING HEALTH RISKS IN CHILDREN ASSOCIATED WITH EXPOSURE TO CHEMICALS

UNICEF Strategic Plan,

Transcription:

MONITORING HEALTH INEQUALITY An essential step for achieving health equity ILLUSTRATIONS OF FUNDAMENTAL CONCEPTS

The examples in this publication draw from the topic of reproductive, maternal and child health, where comparable data across many countries are publicly available. Maps and figures are based on data that were derived from re-analysis of Demographic and Health Surveys (DHS) and Multiple Indicator Cluster Surveys (MICS) micro-data. For more information about these data and the topic of health inequality please visit the Health Equity Monitor on the Global Health Observatory (http://www.who.int/gho/health_equity/en/). Detailed information about the criteria used to calculate the indicator numerator and denominator values used in these analyses is available in the WHO Indicator and Measurement Registry, under the topic Health Equity Monitor (http://www. who.int/gho/indicator_registry/en/). WHO/FWC/GER/2014.1 World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications whether for sale or for non-commercial distribution should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. This work is a collaboration between the Department of Health Statistics and Information Systems and the Gender, Health Equity and Human Rights (GER) Team, and is a product of GER mainstreaming. Ahmad Reza Hosseinpoor, Nicole Bergen, Anne Schlotheuber and Humna Amjad contributed to the development of this publication and the accompanying videos. The maps were produced by Florence Rusciano. Design and layout: L IV Com Sàrl, Villars-sous-Yens, Switzerland. Printed by the WHO Document Production Services, Geneva, Switzerland.

THE HEALTH OF THE WORLD S POPULATION IS IN A STATE OF INEQUALITY. people have vastly different stories to tell about their health depending on their economic status, level of education, place of residence, sex, age and any other potential base for discrimination. Health inequalities exist across countries, but also within countries. Looking beyond national averages reveals that health levels are different across subgroups of national populations. Inequalities may change over time. Inequalities in health should be reported to convey the current situation and change over time, which can be benchmarked to get a sense of how well a given country or subnational region is performing. Inequalities in health have many faces. It is not enough to say that health varies between the rich and the poor. There are also important differences between males and females, urban and rural residents, highly-educated and less-educated, old and young, etc. The reduction of inequality should be an explicit aim of health agendas and goal-setting. Policies, programmes and practices should prioritize the needs of subgroups that are falling behind. Improving the health of the worst-off translates into better national figures, and helps entire populations realize the right to health. 1

HEALTH INEQUALITIES ARE WIDESPREAD. while national averages can be compared to show inequalities across countries, presenting data according to different population subgroups also reveals important within-country inequalities. Inequalities in child malnutrition are shown by level of mother s education. The following maps illustrate prevalence of stunting in children under five years of age in 72 low- and middle-income countries, by the level of mother s education: no education and secondary school or higher (intermediate category not shown). The level of stunting varies across countries for a given education subgroup. Looking across the two maps, stunting prevalence within each country tended to be lower in the subgroup with a higher level of education. monitoring health inequality HOW MUCH DOES CHILD MALNUTRITION VARY ACROSS EDUCATION SUBGROUPS WITHIN COUNTRIES? EXPLORE THIS QUESTION BY SCANNING THE QR CODE TO VIEW A SHORT VIDEO CLIP. To see all videos about health inequality monitoring visit: www.who.int/gho/health_equity/videos/en/index.html 2

stunting prevalence in children under five years of age in 72 low- and middle-income countries, by mother s education* Prevalence (%) <20 20.0 29.9 30.0 39.9 40.0 Not reported** Data not available Not applicable no education 0 1,700 3,400 850 Kilometers Prevalence (%) <20 20.0 29.9 30.0 39.9 40.0 Not reported** Data not available Not applicable *Source: DHS and MICS, 2005 2012. **Estimate is based on fewer than 25 cases. secondary school+ 0 1,700 3,400 850 Kilometers An essential step for achieving health equity 3

HEALTH INEQUALITY IS MULTI- DIMENSIONAL. for a given health indicator, the situation of inequality is more fully captured by considering multiple dimensions such as economic status, education, place of residence and sex. Inequalities in child mortality are shown by multiple dimensions of inequality. The following bar charts illustrate under-five mortality rate in 49 low- and-middle income countries, by economic status, mother s education, place of residence and sex. The rate of mortality in children under five years of age was higher among the poorest than the richest subgroup, and the no education subgroup than the secondary school or higher subgroup. Inequality existed between rural and urban subgroups (higher mortality in rural subgroups), and to a lesser extent, between males and females (higher mortality in males). monitoring health inequality 4

under-five mortality in 49 low- and middle-income countries (median levels), by multiple dimensions of inequality* 120 economic status mother s education** place of residence sex 100 deaths per 1000 live births 80 60 40 20 0 poorest 2nd poorest middle 2nd richest richest no education primary school secondary school+ rural urban male female * Source: DHS, 2005 2012. **Data are not available for 10 countries. HOW DO SUBGROUP VARIATIONS IN UNDER-FIVE MORTALITY DIFFER BETWEEN LOW-INCOME COUNTRIES AND MIDDLE- INCOME COUNTRIES? EXPLORE THIS QUESTION BY SCANNING THE QR CODE TO VIEW A SHORT VIDEO CLIP. To see all videos about health inequality monitoring visit: www.who.int/gho/health_equity/videos/en/index.html An essential step for achieving health equity 5

BENCHMARKING PUTS CHANGES IN INEQUALITY IN CONTEXT. countries can be benchmarked against others in the same region or country income grouping to get a sense of whether the country is doing well or has room for improvement. Changes in inequality, together with national average, are shown for reproductive health. The following graph illustrates progress in modern contraceptive use according to both urban/rural inequality and national average, in 41 low- and middle-income countries. The four quadrant view facilitates easy identification of the best-performing countries: those countries with decreasing inequality of modern contraceptive use and increasing national prevalence are located in the bottom right quadrant of the graph. The countries in the top left quadrant reported an increase in inequality and a decrease in national prevalence; here, the situation is worsening. monitoring health inequality In addition to national-level benchmarking using a group of countries in the same region or country income level grouping, benchmarking can be done to gauge relative performance among subnational regions like provinces, states, districts, etc. 6

change in inequality and national average of modern contraceptive use in 41 low- and middle-income countries* The situation is improving for the countries in this quadrant. The situation is worsening for the countries in this quadrant. annual change in difference between urban and rural areas (percentage points) -4 decrease in average increase in inequality -3-2 decrease in average decrease in inequality -1 3 2 1 0 0-1 -2-3 annual change in national average (percentage points) 1 2 increase in average increase in inequality 3 4 increase in average decrease in inequality Circles represent countries; each country is shown on the figure by one circle. *Source: DHS and MICS, 1995 2012. Data were taken from two time points (1995 2004 and 2005 2012), spanning on average, 10 years. WHICH COUNTRIES HAD INCREASED NATIONAL AVERAGE OF MODERN CONTRACEPTIVE USE AND DECREASED URBAN/RURAL INEQUALITY? EXPLORE THIS QUESTION BY SCANNING THE QR CODE TO VIEW A SHORT VIDEO CLIP. To see all videos about health inequality monitoring visit: www.who.int/gho/health_equity/videos/en/index.html An essential step for achieving health equity 7

HEALTH INEQUALITIES INFORM POLICY. inequalities span populations, so it is important to consider the gradient of health across all population subgroups. observing patterns in disaggregated data helps to indicate appropriate approaches to address inequality. Patterns of inequality are shown across disaggregated data. Health service coverage is shown across subgroups of economic status, illustrating four distinct patterns of inequality. The complete coverage pattern has coverage of 100% or close to 100% in all subgroups. Marginal exclusion is characterized by markedly lower coverage in the poorest subgroup than the other four subgroups. A linear pattern has gradual increases from the poorest to the richest subgroup, and mass deprivation has low or very low coverage in all subgroups except the richest. monitoring health inequality 8

patterns of inequality in health service coverage, by economic status 100 80 coverage (%) 60 40 20 0 poorest 2nd poorest middle 2nd richest richest Complete coverage shows a need for continued monitoring. Marginal exclusion requires action targeted to the underserved. An incremental linear pattern requires a combined universal and targeted approach. Mass deprivation requires universal action oriented to the whole population. WHICH COUNTRIES DEMONSTRATE CHARACTERISTIC PATTERNS OF INEQUALITY IN BIRTHS ATTENDED BY SKILLED HEALTH PERSONNEL, DISAGGREGATED BY ECONOMIC STATUS? EXPLORE THIS QUESTION BY SCANNING THE QR CODE TO VIEW A SHORT VIDEO CLIP. To see all videos about health inequality monitoring visit: www.who.int/gho/health_equity/videos/en/index.html An essential step for achieving health equity 9

ESSENTIAL STEPS FORWARD FOR ACHIEVING HEALTH EQUITY health inequalities persist and should be measured in diverse health topics. identifying health inequalities and their drivers is essential for achieving health equity as well as gender equality and the right to health. monitoring health inequality Health information systems are the foundation for monitoring health inequality. Strengthening equity-oriented health information systems of member states requires capacity building for improved collection, analysis and reporting of health data from population subgroups. Data collection. Regularly-occurring and standardized data collection practices should strive to ensure that the data used for health inequality monitoring are reliable, of high-quality, and comparable across settings and over time. The two types of data required for health inequality monitoring data about health and data about dimensions of inequality, like economic status, education level, place of residence and sex should be collected from a single source, or linked together from different sources. Data analysis. Developing the proficiency to conduct regular health inequality analyses requires dedicated resources to build the specialized technical knowledge, analytic skills and best practices that inform data analyses. Reporting. Clear and salient messages from health inequality data analyses should be reported, achieving a balance between presenting comprehensible messages and maintaining sufficient technical accuracy and rigor. Reporting should be targeted to the needs and abilities of the audience to which the messages are presented. 10

Visualization technologies make health data accessible, easy-to-navigate and meaningful to diverse audiences. Diverse audiences (policy makers, health professionals, researchers, media, public, etc.) can engage in data exploration and benchmarking, creating customized data views according to their interests. HOW CAN HEALTH INEQUALITY DATA BE PRESENTED INTERACTIVELY? EXPLORE THIS QUESTION BY SCANNING THE QR CODE TO VIEW A SHORT VIDEO CLIP. To see all videos about health inequality monitoring visit: www.who.int/gho/health_equity/videos/en/index.html An essential step for achieving health equity 11

More information about the state of inequality, including interactive data visualization, will be available in early 2015 in the full report State of inequality: reproductive, maternal and child health. For other products on the topic of health inequality monitoring, please visit www.who.int/gho/health_equity/en/

Everyone Everywhere Always www.who.int/gho/health_equity/en/ DEPARTMENT OF HEALTH STATISTICS AND INFORMATION SYSTEMS GENDER, HEALTH EQUITY AND HUMAN RIGHTS TEAM WORLD HEALTH ORGANIZATION 20, AVENUE APPIA CH-1211 GENEVA 27 SWITZERLAND WHO/FWC/GER/2014.1